... Toronto Stock Exchange Symbol: DND ...MISSISSAUGA ON Feb. 11 / CipherPharmaceutica...In December 2007 Cipher appealed the decision in the Agency's May 200...As a consequence Cipher is suspending its appeal at this time andexp...

In December 2007, Cipher appealed the decision in the Agency's May 2007
Approvable Letter through the Formal Dispute Resolution process. On
February 1, 2008, the Company announced that it received a written response
from the FDA regarding its first stage of appeal. In the response, the
Acting Director of the Office of Drug Evaluation II, Center for Drug
Evaluation and Research supported the Division's approvable action. In a
subsequent discussion with Cipher, the Agency informed Cipher of the new
analysis as an alternative to continuing the Formal Dispute Resolution
process.

As a consequence, Cipher is suspending its appeal at this time and
expects to meet with the Division in the near future to obtain further
details on the additional analysis.

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals is a drug development company focused on
commercializing novel formulations of successful, currently marketed
molecules using advanced drug delivery technologies. Cipher's strategy is
to in-license products that incorporate proven drug delivery technologies
and advance them through the clinical development and regulatory approval
stages, after which the products are out-licensed to international
partners. Because Cipher's products are based on proven technology
platforms applied to currently marketed drugs, they are expected to have
lower approval risk, shorter development timelines and significantly lower
development costs. The Company's lead compound, CIP-FENOFIBRATE, received
final approval from the U.S. Food and Drug Administration and Health Canada
in the first quarter of 2006. The product is being marketed in the United
States by ProEthic Pharmaceuticals under the label Lipofen(TM). In
addition, Cipher is developing formulations of the pain reliever tramadol
and the acne treatment isotretinoin.

Cipher is listed on the Toronto Stock Exchange under the symbol 'DND'
and has approximately 24 million shares outstanding. For more information,
please visit http://www.cipherpharma.com.

Forward-Looking Statements

Statements made in this news release, other than those concerning
historical financial information, may be forward-looking and therefore
subject to various risks and uncertainties. Some forward-looking statements
may be identified by words like "may", "will", "anticipate", "estimate",
"expect", "intend", or "continue" or the negative thereof or similar
variations. Certain material factors or assumptions are applied in making
forward-looking statements and actual results may differ materially from
those expressed or implied in such statements. Factors that could cause
results to vary include those identified in the Company's Annual
Information Form and other filings with Canadian securities regulatory
authorities, such as the applicability of patents and proprietary
technology; possible patent litigation; regulatory approval of products in
the Company's pipeline; changes in government regulation or regulatory
approval processes; government and third-party payer reimbursement;
dependence on strategic partnerships for product candidates and
technologies, marketing and R&D services; meeting projected drug
development timelines and goals; intensifying competition; rapid
technological change in the pharmaceutical industry; anticipated future
losses; the ability to access capital to fund R&D; and the ability to
attract and retain key personnel. All forward-looking statements presented
herein should be considered in conjunction with such filings. The Company
does not undertake to update any forward-looking statements; such
statements speak only as of the date made.

(Date:10/13/2017)... ... 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is ... vendors and unique items from across the nation, this holiday-themed event will raise funds ... by the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. ...

(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...

(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...

(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...

(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based ... and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored ... 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, ...

(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 /PRNewswire/ ... ratings for global supply chains, has published the first annual edition of ... performance of more than 20,400 companies evaluated by EcoVadis, based on Scorecard ... and 2016. ... Global CSR Risk & Performance Index ...